Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 10/20 | 0.44 |
| ▸ | CASR | P41180 | 4/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.42 |
| ▸ | FNTB | P49356 | 1/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12519809 | 0.78 | CASR (0.56) | TACR1CASRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL12519812 | 0.78 | CASR (0.56) | TACR1CASRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL12444909 | 0.75 | TACR1 (0.48) | TACR1CASRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL12444912 | 0.75 | TACR1 (0.48) | TACR1CASRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL22050521 | 0.75 | TACR1 (0.64) | TACR1 | |
| SCHEMBL21995083 | 0.75 | TACR1 (0.64) | TACR1 | |
| SCHEMBL22457178 | 0.74 | TACR1 (0.62) | TACR1 | |
| SCHEMBL21994971 | 0.74 | TACR1 (0.62) | TACR1 | |
| SCHEMBL21381339 | 0.74 | HTR2A (0.49) | TACR1CASRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL433146 | 0.74 | CYP1A2 (0.58) | TACR1SLC1A3SLC1A2SLC1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3205639-B1 | AGENT FOR INTRODUCING A PROTECTING GROUP FOR HYDROXY GROUP AND/OR FOR MERCAPTO GROUP | UNIV KYUSHU NAT UNIV CORP (JP) | 2021-08-11 | — | — | EP | disclosed |
| US-10160694-B2 | Agent for introducing protecting group for hydroxy group and/or mercapto group | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2018-12-25 | — | — | US | disclosed |
| US-20170305809-A1 | AGENT FOR INTRODUCING PROTECTING GROUP FOR HYDROXY GROUP AND/OR MERCAPTO GROUP | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-10-26 | — | — | US | disclosed |
| EP-3205639-A1 | PROTECTING-GROUP INTRODUCING AGENT FOR HYDROXY GROUP AND/OR MERCAPTO GROUP | Kyushu University, National University Corporation (JP) | 2017-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10160694-B2 | Agent for introducing protecting group for hydroxy group and/or mercapto group | GRHPR, AOX1, MSRB3 | TACR1 1289/4885CASR 3364/4885FNTA 4066/4885 |
| US-20170305809-A1 | AGENT FOR INTRODUCING PROTECTING GROUP FOR HYDROXY GROUP AND/OR MERCAPTO GROUP | GRHPR, AOX1, MSRB3 | TACR1 1289/4885CASR 3364/4885FNTA 4066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.